Floatz logo

Keppra

MDS (Myelodysplastic Syndrome)

Center for International Blood and Marrow Transplant ResearchPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

6 Active assets in the MDS (Myelodysplastic Syndrome) cohort.

Asset / SponsorPhaseRating
Ptcy
Center for International Blood and Marrow Transplant Research
Phase 2CCC
Monalizumab
Istituto Clinico Humanitas
Phase 2CCC
Lorazepam
Center for International Blood and Marrow Transplant Research
Phase 2CCC
Fosphenytoin
Center for International Blood and Marrow Transplant Research
Phase 2CCC
ard103
ARCE Therapeutics, Inc.
Phase 1/2CC

View all 9 →

Same molecule, other indications

Keppra is also rated in:

Epilepsy, PartialDormant
A
Indicative ·
80 / 100
View asset →
Epilepsy, Tonic-clonicDormant
BBB
Indicative ·
78 / 100
View asset →
epilepsyDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →